Detalhe da pesquisa
1.
Acetyl-CoA carboxylase 1 depletion suppresses de novo fatty acid synthesis and mitochondrial ß-oxidation in castration-resistant prostate cancer cells.
J Biol Chem
; 299(1): 102720, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36410440
2.
CancerMIRNome: an interactive analysis and visualization database for miRNome profiles of human cancer.
Nucleic Acids Res
; 50(D1): D1139-D1146, 2022 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34500460
3.
Arginase 2 is a Diagnostic and Prognostic Marker for Prostate Cancer and Is Associated with Metabolism.
Altern Ther Health Med
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581330
4.
N6-methyladenosine modified lncRNAs signature for stratification of biochemical recurrence in prostate cancer.
Hum Genet
; 2023 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37758909
5.
Ferrocene-Based Polymeric Nanoparticles Carrying Doxorubicin for Oncotherapeutic Combination of Chemotherapy and Ferroptosis.
Small
; 19(2): e2205024, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36398604
6.
Extended application of genomic selection to screen multiomics data for prognostic signatures of prostate cancer.
Brief Bioinform
; 22(3)2021 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32898860
7.
Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS/STING/IRF3 pathway.
J Transl Med
; 21(1): 884, 2023 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38057852
8.
Inference of Chromosome-Length Haplotypes Using Genomic Data of Three or a Few More Single Gametes.
Mol Biol Evol
; 37(12): 3684-3698, 2020 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668004
9.
Novel immune-related signature for risk stratification and prognosis in prostatic adenocarcinoma.
Cancer Sci
; 112(10): 4365-4376, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34252262
10.
DCUN1D1 promotes tumour progress in prostate cancer and its effect on DU145 in vitro.
J Pak Med Assoc
; 71(2(A)): 473-478, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33819231
11.
ARNT-dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer.
Mol Carcinog
; 59(8): 897-907, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32319143
12.
Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer.
BMC Cancer
; 20(1): 289, 2020 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32252682
13.
KIF4A: A potential biomarker for prediction and prognostic of prostate cancer.
Clin Invest Med
; 43(3): E49-59, 2020 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32971585
14.
Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Mol Cancer
; 18(1): 122, 2019 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31387585
15.
Expression of PD-L1 in tumor-associated nerves correlates with reduced CD8+ tumor-associated lymphocytes and poor prognosis in prostate cancer.
Int J Cancer
; 144(12): 3099-3110, 2019 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30537104
16.
GDCRNATools: an R/Bioconductor package for integrative analysis of lncRNA, miRNA and mRNA data in GDC.
Bioinformatics
; 34(14): 2515-2517, 2018 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29509844
17.
Modeling the Complex Exposure History of Smoking in Predicting Bladder Cancer: A Pooled Analysis of 15 Case-Control Studies.
Epidemiology
; 30(3): 458-465, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30601243
18.
The efficacy and safety of retroperitoneoscopic renal pedicle ligation of lymphatic disconnection versus open surgery in the treatment of chyluria: A systematic review and meta-analysisâ©.
Clin Nephrol
; 91(4): 211-221, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30802203
19.
Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer.
J Cell Biochem
; 119(9): 7245-7255, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29797600
20.
Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Mol Cancer
; 22(1): 56, 2023 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36941584